PHF19 before and post induction treatment possess favorable potency of reflecting treatment response to protease inhibitors, event-free survival, and overall survival in multiple myeloma patients

CONCLUSION: PHF19 is aberrantly high and declines post induction therapy, which simultaneously reflects unfavorable treatment response to protease inhibitors as well as shorter EFS and OS in MM patients.PMID:38511642 | DOI:10.1080/16078454.2024.2331389

Source: Hematology - March 21, 2024 Category: Hematology Authors: Hongyu An Shiming Chen Xin Zhang Shandong Ke Jinyong Ke Yalan Lu Source Type: research